Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China flag China · Delayed Price · Currency is CNY
5.07
-0.12 (-2.31%)
Sep 10, 2026, 3:04 PM CST

SHE:300239 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
453.4482.38532.1748.69356.11225.87
Cash & Short-Term Investments
453.4482.38532.1748.69356.11225.87
Cash Growth
-12.90%-9.34%-28.93%110.24%57.66%370.09%
Accounts Receivable
294.88252.85333.81302.92335.79302.47
Other Receivables
1.061.021.291.463.155.19
Receivables
295.94253.87335.1304.38338.93307.66
Inventory
398.2401.37354.46281.53317.84346.02
Other Current Assets
8.6210.8412.961511.0113.04
Total Current Assets
1,1561,1481,2351,3501,024892.59
Property, Plant & Equipment
1,2501,1951,2041,1631,019966.9
Long-Term Investments
17.9419.1221.0524.4528.3234.88
Other Intangible Assets
132.42135.79143.26144.84152.14174.6
Long-Term Deferred Tax Assets
19.6118.213.0213.6511.8410.67
Long-Term Deferred Charges
3.213.262.96.444.639.46
Other Long-Term Assets
47.4329.626.1140.2468.2123.13
Total Assets
2,6262,5502,6252,7422,3082,112

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
191.19152.18216.07187.32124.79141.59
Accrued Expenses
13.0528.3728.3425.7224.3724.46
Short-Term Debt
---5.842.0750.52
Current Portion of Long-Term Debt
8.744.576.750.0441.02-
Current Income Taxes Payable
7.82.745.025.7494.45
Current Unearned Revenue
8.297.519.927.0214.294.8
Other Current Liabilities
45.2240.4857.6869.26100.73195.57
Total Current Liabilities
274.29235.85323.77300.94316.26421.39
Long-Term Debt
499.64493.7471.9462.82152-
Long-Term Unearned Revenue
53.0950.2548.5145.1648.6749.64
Long-Term Deferred Tax Liabilities
35.7436.6931.3229.925.3427.56
Other Long-Term Liabilities
101010101010
Total Liabilities
872.76826.49885.5848.82552.26508.58

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
593.62593.61593.61593.6593.6593.6
Additional Paid-In Capital
644.47644.38644.38635.82635.82635.88
Retained Earnings
546.63516.22476.46403.54299.09193.21
Treasury Stock
-56.11-56.11----
Comprehensive Income & Other
25.0925.125.125.1--
Total Common Equity
1,7541,7231,7401,6581,5291,423
Minority Interest
---0.12235.13227.35180.97
Shareholders' Equity
1,7541,7231,7391,8931,7561,604
Total Liabilities & Equity
2,6262,5502,6252,7422,3082,112

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
508.38498.27478.65468.71195.0950.52
Net Cash (Debt)
-54.98-15.8853.45279.98161.02175.35
Net Cash Growth
---80.91%73.88%-8.17%-
Net Cash Per Share
-0.09-0.030.080.460.270.31
Filing Date Shares Outstanding
594.23583.03593.61593.6593.6593.6
Total Common Shares Outstanding
594.23583.03593.61593.6593.6593.6
Working Capital
881.87912.61910.861,049707.64471.21
Book Value Per Share
2.952.962.932.792.572.40
Tangible Book Value
1,6211,5871,5961,5131,3761,248
Tangible Book Value Per Share
2.732.722.692.552.322.10
Buildings
-699.98653.56550.38552.09522.11
Machinery
-907.02823.47647.13640.8612.12
Construction In Progress
-150.86204.96364.94160.2994.1